91 related articles for article (PubMed ID: 6360768)
1. Relative roles of insulin clearance and insulin sensitivity in the prebreakfast increase in insulin requirements in insulin-dependent diabetic patients.
Skor DA; White NH; Thomas L; Santiago JV
Diabetes; 1984 Jan; 33(1):60-3. PubMed ID: 6360768
[TBL] [Abstract][Full Text] [Related]
2. Insulin clearance contributes to the variability of nocturnal insulin requirement in insulin-dependent diabetes mellitus.
Dux S; White NH; Skor DA; Santiago JV
Diabetes; 1985 Dec; 34(12):1260-5. PubMed ID: 3905459
[TBL] [Abstract][Full Text] [Related]
3. Influence of growth hormone on overnight insulin requirements in insulin-dependent diabetes.
Skor DA; White NH; Thomas L; Santiago JV
Diabetes; 1985 Feb; 34(2):135-9. PubMed ID: 2857143
[TBL] [Abstract][Full Text] [Related]
4. Alterations in insulin clearance and hepatic blood flow during the night do not contribute to the 'dawn phenomenon' in type 1 diabetes.
Widmer A; Keller U; Pasquel M; Berger W
Horm Res; 1988; 29(5-6):197-201. PubMed ID: 3065206
[TBL] [Abstract][Full Text] [Related]
5. Examination of the role of the pituitary-adrenocortical axis, counterregulatory hormones, and insulin clearance in variable nocturnal insulin requirements in insulin-dependent diabetes.
Skor DA; White NH; Thomas L; Shah SD; Cryer PE; Santiago JV
Diabetes; 1983 May; 32(5):403-7. PubMed ID: 6341122
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of dawn phenomenon without change in insulin clearance in patients with insulin-dependent diabetes mellitus.
Campbell PJ; Gerich JE
Diabetes; 1986 Jul; 35(7):749-52. PubMed ID: 3522315
[TBL] [Abstract][Full Text] [Related]
7. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
[TBL] [Abstract][Full Text] [Related]
8. Predicting insulin requirements for a portable insulin pump using the Biostator. Evidence for reversible insulin resistance in poorly controlled type I diabetics.
Mayfield RK; Sullivan FM; Colwell JA; Wohltmann HJ
Diabetes; 1983 Oct; 32(10):908-14. PubMed ID: 6352376
[TBL] [Abstract][Full Text] [Related]
9. Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon.
De Feo P; Perriello G; Ventura MM; Calcinaro F; Basta G; Lolli C; Cruciani C; Dell'Olio A; Santeusanio F; Brunetti P
Diabetologia; 1986 Aug; 29(8):475-80. PubMed ID: 3530862
[TBL] [Abstract][Full Text] [Related]
10. The effect of intraperitoneal insulin delivery on carbohydrate metabolism in type 1 (insulin-dependent) diabetic patients.
Monti LD; Piatti PM; Home PD; Tomson C; Alberti KG
Diabetes Res Clin Pract; 1992 Mar; 15(3):237-44. PubMed ID: 1576923
[TBL] [Abstract][Full Text] [Related]
11. Overnight basal insulin requirements in insulin dependent diabetics.
Vague P; Moulin JP; Souid J; Lassmann V; Vialettes B
Diabete Metab; 1983 Dec; 9(4):288-91. PubMed ID: 6365641
[TBL] [Abstract][Full Text] [Related]
12. Failure of current insulin regimes to meet the overnight requirements of adolescents with insulin-dependent diabetes.
Edge JA; Matthews DR; Dunger DB
Diabetes Res; 1990 Nov; 15(3):109-12. PubMed ID: 2132202
[TBL] [Abstract][Full Text] [Related]
13. Acute effect of glyburide on insulin sensitivity in type I diabetic patients.
Garrel DR; Picq R; Bajard L; Harfouche M; Tourniaire J
J Clin Endocrinol Metab; 1987 Nov; 65(5):896-900. PubMed ID: 3117833
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes.
Yki-Järvinen H; Koivisto VA
J Clin Endocrinol Metab; 1984 Apr; 58(4):659-66. PubMed ID: 6365945
[TBL] [Abstract][Full Text] [Related]
15. Nighttime insulin kinetics and glycemic control in type 1 diabetes patients following administration of an intermediate-acting lispro preparation.
Janssen MM; Casteleijn S; Devillé W; Popp-Snijders C; Roach P; Heine RJ
Diabetes Care; 1997 Dec; 20(12):1870-3. PubMed ID: 9405909
[TBL] [Abstract][Full Text] [Related]
16. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
Polonsky KS; Licinio-Paixao J; Given BD; Pugh W; Rue P; Galloway J; Karrison T; Frank B
J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia decreases glucose uptake in type I diabetes.
Yki-Järvinen H; Helve E; Koivisto VA
Diabetes; 1987 Aug; 36(8):892-6. PubMed ID: 3297883
[TBL] [Abstract][Full Text] [Related]
18. [Insulin sensitivity and hepatic glucose production: nycthemeral variations].
Gautier JF; Cathelineau G
Diabetes Metab; 1997 Nov; 23 Suppl 4():35-8. PubMed ID: 9463022
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
[TBL] [Abstract][Full Text] [Related]
20. Early morning hyperglycemia in insulin-dependent diabetes: acute and sustained effects of cholinergic blockade.
Atiea JA; Creagh F; Page M; Owens DR; Scanlon MF; Peters JR
J Clin Endocrinol Metab; 1989 Aug; 69(2):390-5. PubMed ID: 2666430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
